Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
deals
life sciences
national blog main
boston blog main
boston top stories
fda
national top stories
boston
medical devices
new york blog main
san francisco blog main
startups
alirocumab
alnylam pharmaceuticals
amgen
atrial fibrillation
boston scientific
cancer
cancer immunotherapy
center for medicare and medicaid services
clinical trial
clinical trials
companion diagnostic
cryterion medical
daniel o'day
detroit
detroit blog main
detroit top stories
evolocumab
food and drug administration
foundation medicine
foundationone cdx
foundationone heme
genentech
genetic testing
inclisiran
investing
invitae
mergers & acquisitions
What
acquire
5
×
deal
billion
agreed
business
cash
device
medical
ability
adding
adds
array
atrial
babies
big
bio
boston
brings
broad
cholesterol
company
compound
confidence
continues
cost
cryterion
didn’t
drug
expand
extremities
fda
fibrillation
foundation
gain
genentech
genetic
giant
heart
invitae
low
Language
unset
Current search:
acquire
×
biotech
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
@xconomy.com
4 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine